In vitro experiments showed that a subset of combination therapy melanoma cells was sensitive to mTORC1 inhibition.
[Oncogene]
Sorry, but the selected Zotpress account can't be found.
Home Newsletters Dermal Cell News Targeting mTOR Signaling Overcomes Acquired Resistance to Combined BRAF and MEK Inhibition...
